Marshall Wace North America’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,011
Closed -$164K 1611
2018
Q4
$164K Buy
+2,011
New +$183K ﹤0.01% 991
2018
Q3
Sell
-46,588
Closed -$5.05M 991
2018
Q2
$5.05M Buy
46,588
+43,416
+1,369% +$4.67M 0.03% 508
2018
Q1
$330K Buy
+3,172
New +$369K ﹤0.01% 1243
2017
Q3
Sell
-44,079
Closed -$3.92M 1286
2017
Q2
$3.92M Sell
44,079
-149,881
-77% -$13.2M 0.03% 575
2017
Q1
$17.5M Buy
+193,960
New +$16.7M 0.14% 189

Other funds holding CRI

Marshall Wace North America's CRI Position: Q1 2019 in Review

Marshall Wace North America sold out of Carter's (CRI) in Q1 2019, closing a stake of 2,011 shares — an estimated $164K sold.

Marshall Wace North America first reported a position in CRI in Q1 2017 and held it in 5 quarters. The position peaked at $17.5M in Q1 2017. 320 funds tracked by Wall St. Rank hold CRI as of Q1 2019.

  • Marshall Wace North America reported no remaining Carter's position as of Q1 2019 after selling out during the quarter.
  • Marshall Wace North America sold 2,011 Carter's shares in Q1 2019, an estimated $164K.
  • Marshall Wace North America first reported a position in Carter's in Q1 2017 and held it in 5 quarters.
  • Marshall Wace North America's Carter's position peaked at $17.5M in Q1 2017.
  • 320 funds tracked by Wall St. Rank held Carter's as of Q1 2019.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.